Breaking News Oct 26, 2026 · 1 min read

Corxel US to go public via SPAC merger with Amanat Acquisition Corp

Corxel Pharmaceuticals, a clinical-stage obesity biopharma, announced a definitive business combination agreement with Amanat Acquisition Corp (Nasdaq: SLIM) to become a publicly listed company. The deal would create a publicly traded obesity-focused biopharmaceutical company, per Globe Newswire.

Source:
globenewswire.com: https://www.globenewswire.com/news-release/2026/10/26/3387902/0/en/corxel-us-and-amanat-acquisition-corp-announce-definitive-business-combination-agreement-to-create-publicly-listed-obesity-focused-biopharmaceutical-company.html

Not financial advice. For informational and educational purposes only.

Track your live portfolio alongside our daily institutional research

Connect your brokerage in 60 seconds and get full access to Position Tracker Substack research inside your dashboard.

Start your free trial →